Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival
Pseudomyxoma peritonei (PMP) is ideally treated by cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC), leading to significant morbidity. Beyond the histologic grade, the prognosis lies in the completeness of cytoreduction (CC-score of 0/1 vs. 2/3) and the severe compl...
Main Authors: | Vahan Kepenekian, Amaniel Kefleyesus, David Keskin, Nazim Benzerdjeb, Isabelle Bonnefoy, Laurent Villeneuve, Omar Alhadeedi, Abeer Al-Otaibi, Alexandre Galan, Olivier Glehen, Julien Péron, Pascal Rousset |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/18/4434 |
Similar Items
-
Clinicopathological Characteristics of Pseudomyxoma Peritonei Originated from Ovaries
by: Yan F, et al.
Published: (2020-08-01) -
A unique presentation of superinfected pseudomyxoma peritonei secondary to a low-grade appendiceal mucinous neoplasm
by: Brianne J. Sullivan, et al.
Published: (2019-02-01) -
A case of Pseudomyxoma Peritonei of an unexpected origin
by: Marie Csanyi-Bastien, et al.
Published: (2021-12-01) -
Mucinous Adenocarcinoma of the Urachal Remnant with Pseudomyxoma Peritonei
by: Benjamin W Lamb, et al.
Published: (2010-05-01) -
Role of Epithelial–Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments
by: Maria Luisa Calabrò, et al.
Published: (2020-11-01)